Metraipolis › archive › dc_fa498d7cc57f
Alirocumab — Wikipedia (en)
- Source
- Wikipedia (en)
- Original
- https://en.wikipedia.org/wiki/Alirocumab
- License (as archived)
- CC-BY-SA-4.0
- Archived
- 2026-11-08T12:25:45.581Z
- SHA-256 of the archived text
167c7eacb1760b351461e052d2e671f7266b1676eeadd584e2514ce683b25cea- Stable URL of this page
https://metraipolis.com/documento/dc_fa498d7cc57f
How to cite
Alirocumab — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/Alirocumab (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_fa498d7cc57f (Metraipolis archive dc_fa498d7cc57f, sha256 167c7eacb1760b351461e052d2e671f7266b1676eeadd584e2514ce683b25cea)
BibTeX
@misc{dcfa498d7cc57f,
title = {Alirocumab — Wikipedia (en)},
howpublished = {Wikipedia (en)},
url = {https://en.wikipedia.org/wiki/Alirocumab},
note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_fa498d7cc57f; sha256 167c7eacb1760b351461e052d2e671f7266b1676eeadd584e2514ce683b25cea},
year = {2026}
}Archived text
Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/Alirocumab. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Alirocumab, sold under the brand name Praluent, is a medication used as a second-line treatment for high cholesterol for adults whose cholesterol is not controlled by diet and statin treatment. It is a human monoclonal antibody that belongs to a novel class of anti-cholesterol drugs, known as PCSK9 inhibitors, and it was the first such agent to receive FDA approval. The FDA approval was contingent on the completion of further clinical trials to better determine efficacy and safety. Common side effects include nasopharyngitis (cold), injection site reactions, and influenza. It was approved for medical use in the United States and in the European Union in 2015. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico). Fonte: Wikipedia in inglese, voce «Alirocumab» — https://en.wikipedia.org/wiki/Alirocumab Wikidata Q4726914: «composto chimico» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q4726914 Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/Alirocumab?action=history). Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza. Estratto dell'introduzione non modificato nel contenuto; revisione 1358348551, consultata il 2026-11-08T12:21:35.603Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: f70700339789081d0cbb691311344de4d80faf439f07e8a226b5bc33e89cb41f